Subscription Services  |  Advertising Opportunities  |  About Us  |  Contact Us  |  Editorial Calendar  |  Submission Guidelilnes

Home  |  Current News  |  Whitepapers / Webinars  |  Back Issues | Search Articles  |  Resource Directory  |  Events
Featured Articles From The Current Issue

VIEW ENTIRE ISSUE

 

Fiat, Help Remedies, Drug Guarantees, Golf Courses

Derek G. Hennecke continues with part 3 of his 6-part series on lessons learned from other industries.

 

Applying Social Media to Your Business

David F. Scelba continues his multiple part series on effective messaging and communications in the life science industry.  

 

Prefilled Syringes - A Container of Choice for Pharma

Special Feature: Contributor Cindy H. Dubin interviewed leading players in the prefilled syringe market to find out about their offerings and how they are addressing pharma’s needs for safety, ease of use, cost, and product differentiation.

 

Diffusion Kinetics & Permeation Concentration of Human Stratum Corneum Characterization by Terahertz Scanning Reflectometry

Anis Rahman, PhD; Scott Frenchek; Brian Kilfoyle; Leena Patterkine, PhD; Aunik Rahman; and Bozena Michniak-Kohn, PhD; use terahertz reflectometry and spectrometry to investigate the permeation kinetics and concentration profile of active ingredients into the stratum corneum.

 

Bend Research: Problem-Solving in the Pharmaceutical Industry

Drug Development Executive: Dr. Rod Ray, CEO and Chairman at Bend Research, discusses his company’s approach to difficult drug delivery challenges and the core technologies offered by his company.

 

Evonik: Supporting Development & Commercial Cycles of Injectables

Drug Development Executive: Dr. Jean-Luc Herbeaux, the Head of the Health Care Business Line of Evonik, talks about the rationale and success of his company's latest acquisition.

 

Rheumatoid Arthritis Meets Its Match

Jos Raats, PhD, says ModiQuest has undertaken a number of studies into specific anti-Citrulline antibodies and has discovered a subset (family) of rCit-hMabs, which could provide a valuable therapeutic in the treatment of early onset RA.

 

Ezose Sciences: High-Throughput Glycomics for Biomarker Discovery - Bringing Glycan Analysis Into Everyday Research

Executive Summary: Scott Siegel, PhD, VP of Business Development at Ezose, discusses how his unique company is catalyzing progress across an emerging research front.

 

DEPARTMENTS

 

Market News & Trends

 

Advanced Delivery Devices

Intranasal Medication Delivery in Clinical Practice - Its Time Has Come

 

Excipient Update

EXCiPACTTM: A New International GMP & GDP Certification for Pharmaceutical Excipients

 

Technology & Services Showcase

 

External Delivery

The Dominator

Market News & Trends
5/15/2012

5/15/2012

5/15/2012

5/15/2012

5/15/2012

5/15/2012

5/7/2012

5/7/2012

5/7/2012

5/7/2012
Whitepapers / Webinars









 
Industry Events
BIO 2012
June 18-21 Boston MA

Controlled Release Society
July 15 – 18, Quebec, Canada

Partnership Opportunities in Drug Delivery (PODD)
October 1 – 3 Boston, MA

CPhI Worldwide
October 9 – 11, 2012 Madrid, Spain

AAPS
October 14 – 18, Chicago, IL

Universe of Pre-filled Syringes and Autoinjectors
October 15 – 16, Las Vegas, NV

Drug Delivery Partnerships
February 6 – 8, 2013 San Diego CA
 
 Current Issue

Next Issue Highlights

 - Formulatating Liposomes
 - Extended-Release Tablets
 - Microneedle Technology
 - Inhaled Dry Powder Delivery
 - Hot-Melt Extrusion
 - Medicated Chewing Gum

Show Distribution

 - BIO
   June 18 - 21 / Boston, MA
 - Controlled Release Society
   July 15 - 18 Quebec, Canada

Ad Space Closes May 18
Contact – Ralph Vitaro
rvitaro@drug-dev.com
973-299-1200

Drug Development & Delivery Videos
Resource Directory
 Categories
 - Contract Services

 - Drug Delivery Technologies

 - Excipients, Polymers, Liposomes, Lipids & Coatings

 - Machinery & Laboratory Equipment
Technology & Services
Development Services

Xcelience is a premier provider of formulation development and manufacturing solutions with a solid reputation for accelerating early phase small molecule development...

New Technologies

Bend Research has decades of experience and a proven track record of success in advancing pharmaceutical compounds...

Tunable Half-Life Technology  

Novozymes’ tunable half-life technology has been developed to flexibly tune the pharmacokinetic profile of target proteins and peptides...

Contract Diagnostics

ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries...

Subscription Services  |  Advertising Opportunities  |  About Us  |  Contact Us  |  Editorial Calendar  |  Submission Guidelilnes
Current News  |  Whitepapers / Webinars  |  Back Issues | Search Articles  |  Resource Directory  |  Events

Copyright © 2012 Drug Development & Delivery All Rights Reserved.